CARMIEL, Israel, Sept. 7 /PRNewswire-FirstCall/ — Protalix BioTherapeutics, Inc. (NYSE-Amex: PLX) today announced the appointment of Mr. Tzvi Palash as the Company’s Chief Operating Officer. In this newly created position, Mr. Palash will be responsible for overseeing the Company’s manufacturing activities and implementing the expansion phase of the Company’s facility as it transitions from a …
